GLP-1FDA RegulationCompounding Pharmacy
The FDA Crackdown on Compounded GLP-1 Medications
For nearly two years, compounding pharmacies filled a critical gap in the GLP-1 medication market. During the prolonged semaglutide shortage, 503A compounding pharmacies and 503B outsourcing facilities
PlusVirtual TeamMar 17, 2025